SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending due to its anticipated inclusion in the S&P 500, sparking excitement among investors who foresee potential institutional investment and a price surge akin to Palantir's after its inclusion. The community is actively discussing potential short squeezes, target prices, and the impact of the upcoming company summit and potential Federal Reserve rate cuts on the stock's performance. Some investors are cautioning against excessive optimism, citing previous instances where stocks experienced declines post-inclusion.

Aventus

Aventus is trending, with community members highlighting a new partnership with The Truth Network. Bullish sentiment seems to be building with anticipation of a potential listing on a top 10 exchange. Some traders are pointing to the token's low market cap and limited supply as factors that could drive price appreciation.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is trending as investors weigh its dividend yield against recent market performance, with some expressing frustration over underperformance compared to growth-focused ETFs. The community is actively debating whether to hold SCHD for long-term income or rotate into higher-growth opportunities, especially as some point to its heavy weighting in energy and healthcare sectors. Recent discussions also highlight anticipation for the next dividend announcement and how broader economic factors like interest rate cuts and potential tariffs might impact the ETF.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as its community rallies around its potential, citing ongoing developments and a strong, active community. The coin, built on the Solana network, is experiencing increased attention, with community members celebrating new all-time highs. Discussions also highlight upcoming airdrops and staking features, generating excitement for the project's future.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending due to its inclusion in the S&P 500, sparking excitement and after-hours gains. The community is weighing the potential for further upside against concerns of overvaluation and insider selling. Some traders are also discussing option strategies to capitalize on the stock's volatility.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as chatter revolves around potential acquisition bids and analyst optimism for their drug candidate, AXPAXLI, despite recent market volatility. Community members speculate on buyout prices and partnerships, focusing on the upcoming SOL-1 data and its potential impact on valuation. Some traders are weighing OCUL against competitors in the wet AMD space, while others discuss the broader biotech sector trends.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG.X) is trending as holders actively discuss earning Solana ($SOL.X) rewards simply by holding the token, highlighting its potential as a passive income source. The community is also excited about the upcoming Bare Knuckle Fighting Championship (BKFC) event featuring Kimbo Slice Jr., who will be representing $IMG.X, signaling a move towards broader brand visibility and community engagement.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits.

$PAW.X is trending amid community excitement around the PAW Chain ecosystem and its cross-chain interoperability features. Recent medium articles and updates regarding partnerships, projects building on the chain, and a soon-to-happen AMA, are driving bullish sentiment. The community highlights the potential for innovation in DeFi with PAW Chain's scalability and unified liquidity.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is trending as traders discuss its potential upside and key resistance levels, with some eyeing it as a safe haven amid market uncertainty. Community members are actively considering options strategies and anticipating a run toward specific price targets, while also monitoring news related to analyst ratings and potential tariff impacts. Broader discussions involve P&G's role as a defensive stock and its established history of dividend increases.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is currently a hot topic with community members debating its potential for growth and whether it's undervalued compared to other cryptocurrencies like ETH. Discussions also involve staking rewards and upcoming catalysts, such as potential ETF approvals. Despite mixed sentiment, some believe DOT is poised for a significant rally, while others express concerns about its performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?

ETFs to Capitalize on the Novo Nordisk-Septerna Deal

Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk

Danish drug maker Novo Nordisk (NVO) on Tuesday announced an exclusive global collaboration and license agreement with U.S.-based Septerna, Inc. (SEPN) to discover, develop, and commercialise oral small-molecule medicines for obesity, type 2 diabetes, and other cardiometabolic diseases.The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916006">said</a> the deal could be worth up to $2.2 billion. This includes more than $200 million in upfront and near-term milestone payments to Septerna and additional research, development, and commercial milestone payments.The California-based company is also eligible to receive tiered royalties on global net sales of marketed products.Novo Nordisk will cover all research and development expenses for partnered programs under the collaboration.The agreement is expected to close in the second quarter of 2025.The companies will initially commence four development programmes for potential small-molecule therapies directed at select G-protein-coupled receptor (GPCR) targets. GPCRs are a large and diverse family of cell membrane proteins involved in cellular communication.Septerna CEO Jeffrey Finer said that the collaboration provides an opportunity to create multiple oral medicines and provides the company with the operational flexibility and resources to advance its portfolio of other GPCR-targeted programmes.On Stocktwits, retail sentiment around Novo Nordisk fell from ‘bullish’ to ‘bearish’ territory over the past 24 hours while message volume dropped from ‘extremely high’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:629/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_14_at_8_28_57_AM_png_13db4d5cfd.webp" alt="Screenshot 2025-05-14 at 8.28.57 AM.png" width="629" height="64"><figcaption>NVO's Sentiment Meter and Message Volume as of 8:30 a.m. ET on May 14, 2025 | Source: Stocktwits</figcaption></figure> Meanwhile, retail sentiment on Septerna jumped from ‘bearish’ to ‘extremely bullish’ territory while message volume jumped from ‘normal’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:628/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_14_at_8_31_56_AM_png_a149898af9.webp" alt="Screenshot 2025-05-14 at 8.31.56 AM.png" width="628" height="62"><figcaption>SEPN's Sentiment Meter and Message Volume as of 8:35 a.m. ET on May 14, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expressed concerns about the new agreement, opining that Septerna’s pipeline is in the “early stage.”<stembedurl>https://stocktwits.com/NEVER_SAY_TRANSITORY/message/614571231</stembedurl>However, another investor expressed optimism on the stock if it breaks the $12.40 mark.<stembedurl>https://stocktwits.com/Trad3Slinger/message/614572114</stembedurl><a href="https://stocktwits.com/symbol/SEPN">SEPN stock</a> is up by about 70% in premarket trading on Wednesday.The stock is down by 68% this year and nearly 69% over the past 12 months.<a href="https://stocktwits.com/symbol/NVO">NVO stock</a>, meanwhile, is trading nearly 3% higher in pre-market.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nvidia-backed-databricks-acquires-database-startup-neon/chiqpslRbNL">Nvidia, Microsoft-Backed Databricks Bets Big On AI Agents With $1B Neon Takeover: Retail Turns Extremely Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Novo Nordisk logo is displayed on a smartphone with stock market percentages in the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled

Septerna CEO Jeffrey Finer said that the collaboration allows the company to create multiple oral medicines and provides the operational flexibility and resources to advance its portfolio of other GPCR-targeted programmes.

Equity

Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones

Analysts initiated coverage on Septerna, Inc. with Overweight ratings and price targets of $50 and $38. SEPN's innovative platform and potential pipeline make it a promising biopharma player.
read...

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.

SEPN
Septerna Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SEPN News

SEPN Septerna Inc.